Libido in the menopausal woman

Megan Ogilvie discusses women's libido including menopausal hormone treatment, and testosterone supplementation.

Topics

Intro
Play now
Changes to libido over lifespan.
Play now
Changes to Testosterone over lifespan
Play now
Consensus statement for testosterone supplementation
Play now
Indications for testosterone supplementation
Play now
What is a loss of libido?
Play now
How to ask these personal questions.
Play now
Investigations Do we measure testosterone?
Play now
Do we think about lipids?
Play now
Stepped approach to management
Play now
How is AndroFem used?
Play now
Monitoring
Play now
Is it subsidised?
Play now
Why is prescribing low?
Play now
Any side effects?
Play now
Is there ever a place for compounding testosterone?
Play now
Should we be screening these women for breast cancer?
Play now
More information
Play now
Take home messages
Play now

Take home messages

Think about libido first.
Libido is not just about testosterone.
If women have lost their ovarian function, then testosterone is a reasonable trial of treatment.
Use an appropriate product.
Monitor and follow up.

Resources

Testosterone and Women Australasian Menopause Society
Webinar: What’s new - The use of testosterone in women AMS (2021)
Effects of testosterone therapy for women: a systematic review and meta-analysis protocol Syst Rev. (2019)
The Safety of Testosterone Therapy in Women JOGC (2012)
Global Consensus Position Statement on the Use of Testosterone Therapy for Women The Journal of Clinical Endocrinology & Metabolism (2019)
Menopause resources Health Navigator NZ

Patient Resources

Presenter

Megan Ogilvie

Endocrinologist

Megan graduated from University of Auckland and completed specialist endocrine training in Auckland. She undertook postgraduate training at St Bartholomew’s Hospital and subsequently at Middlesex Hospital in London. Megan joined Fertility Associates in 2004 working in the areas of both general and reproductive endocrinology with particular interests in polycystic ovarian syndrome (PCOS), amenorrhoea, menopause and gonadal dysgenesis.